Home/Filings/4/0001193125-26-006294
4//SEC Filing

LEONARD JOHN M 4

Accession 0001193125-26-006294

CIK 0001652130other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:05 PM ET

Size

5.7 KB

Accession

0001193125-26-006294

Insider Transaction Report

Form 4
Period: 2026-01-05
LEONARD JOHN M
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2026-01-05$9.21/sh34,146$314,4851,013,339 total
Holdings
  • Common Stock

    (indirect: By Trust)
    58,415
Footnotes (2)
  • [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
  • [F2]Shares held by the John M. Leonard 2015 Irrevocable Trust.

Documents

1 file

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1
  • filerCIK 0001563584

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:05 PM ET
Size
5.7 KB